NCT06630689 is a NA clinical trial of Dry Full Body Massage in Hyperbilirubinemia, Neonatal, sponsored by meral güven.

Who is sponsoring NCT06630689?

NCT06630689 is sponsored by meral güven.

What drugs are being tested in NCT06630689?

Interventions in NCT06630689: Dry Full Body Massage, Oil Full Body Massage.

What condition does NCT06630689 study?

NCT06630689 studies Hyperbilirubinemia, Neonatal.

Is NCT06630689 still recruiting?

NCT06630689 is currently completed. Last updated 15 October 2024.

Last reviewed 2024-10-15 · How we verify

NCT06630689

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effects of Oil and Dry Neonatal Massage on Hyperbilirubinemia and Comfort

Completed NA Last updated 15 October 2024

What this trial tests

NA trial testing Dry Full Body Massage in Hyperbilirubinemia, Neonatal in 90 participants. Completed in 31 August 2024.

Timeline

1 September 2023

Primary endpoint
30 June 2024

31 August 2024

Quick facts

Lead sponsor	meral güven
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	other
Enrollment	90
Start date	1 September 2023
Primary completion	30 June 2024
Estimated completion	31 August 2024
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Dry Full Body Massage
Oil Full Body Massage

Conditions studied

Hyperbilirubinemia, Neonatal — all drugs for Hyperbilirubinemia, Neonatal →

Sponsor

meral güven

Who can join

Adults 1 Day to 28 Days, any sex, with Hyperbilirubinemia, Neonatal. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The need for infant massage may come to the forefront as a part of routine care in the neonatal intensive care unit to reduce high bilirubin levels in newborns and to reduce the need for phototherapy treatment. This study was planned to investigate the effects of oily and dry neonatal massage on hyperbilirubinemia and comfort.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Hyperbilirubinemia, Neonatal

Currently open trials in the same condition.

NCT03866213 — Validation of a Jaundice Diagnostic and Monitoring Device for Low-Resource Settings · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06630689 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by meral güven
Last refreshed: 15 October 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06630689.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing